These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6124227)

  • 41. Aphakic cystoid macular edema secondary to betaxolol therapy.
    Hesse RJ; Swan JL
    Ophthalmic Surg; 1988 Aug; 19(8):562-4. PubMed ID: 2902544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.
    Plager DA; Whitson JT; Netland PA; Vijaya L; Sathyan P; Sood D; Krishnadas SR; Robin AL; Gross RD; Scheib SA; Scott H; Dickerson JE;
    J AAPOS; 2009 Aug; 13(4):384-90. PubMed ID: 19683191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Results of the betaxolol versus placebo treatment trial in ocular hypertension.
    Kamal D; Garway-Heath D; Ruben S; O'Sullivan F; Bunce C; Viswanathan A; Franks W; Hitchings R
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):196-203. PubMed ID: 12644943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic and systemic side effects of ocular beta-adrenergic antagonists in anesthetized dogs.
    Svec AL; Strosberg AM
    Invest Ophthalmol Vis Sci; 1986 Mar; 27(3):401-5. PubMed ID: 2869005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Betaxolol and acetazolamide. Combined ocular hypotensive effect.
    Smith JP; Weeks RH; Newland EF; Ward RL
    Arch Ophthalmol; 1984 Dec; 102(12):1794-5. PubMed ID: 6391442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans.
    Kanno M; Araie M; Koibuchi H; Masuda K
    Br J Ophthalmol; 2000 Mar; 84(3):293-9. PubMed ID: 10684841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metipranolol--a new beta-blocker].
    Kruse W
    Klin Monbl Augenheilkd; 1983 Jun; 182(6):582-4. PubMed ID: 6135820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Beta-blockers in the treatment of open-angle glaucoma].
    Potocký M; Vodrázková E
    Cesk Slov Oftalmol; 1996 Nov; 52(6):399-402. PubMed ID: 9072217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-term clinical trial evaluating the efficacy of the combination of apraclonidine 0.5% solution and betaxolol 0.25% suspension.
    Lamberti G; Pignalosa B; Fusco R; Pignalosa G; Di Govanni A; Sebastiani A
    Acta Ophthalmol Scand Suppl; 1997; (224):20-1. PubMed ID: 9589713
    [No Abstract]   [Full Text] [Related]  

  • 50. [Preservative-free betaxolol for POAG patients: evaluation of hypotensive effect and ocular surface safety].
    Onischenko AL; Dimaksyan MV; Kolbasko AV; Zilina NM
    Vestn Oftalmol; 2015; 131(2):76-80. PubMed ID: 26080587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Combination Glaucoma Therapies on β-Blocker Exposure.
    Xu K; Campbell EL; Gill SS; Nesdole R; Campbell RJ
    J Glaucoma; 2017 Feb; 26(2):e107-e109. PubMed ID: 28059862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma.
    Allen RC; Hertzmark E; Walker AM; Epstein DL
    Am J Ophthalmol; 1986 May; 101(5):535-41. PubMed ID: 3518464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity.
    Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF
    Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?
    Yarangümeli A; Kural G
    Expert Opin Pharmacother; 2004 May; 5(5):1071-81. PubMed ID: 15155109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.
    Strahlman E; Tipping R; Vogel R
    Arch Ophthalmol; 1995 Aug; 113(8):1009-16. PubMed ID: 7639651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
    Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
    Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow.
    Morsman CD; Bosem ME; Lusky M; Weinreb RN
    Eye (Lond); 1995; 9 ( Pt 3)():344-7. PubMed ID: 7556745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atenolol versus propranolol. A comparison of ocular hypotensive effect of an oral dose.
    Macdonald MJ; Cullen PM; Phillips CI
    Br J Ophthalmol; 1976 Nov; 60(11):789-91. PubMed ID: 12782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
    Diggory P; Cassels-Brown A; Fernandez C
    Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.